ICF Process IRB Webinar 11/13/2014
Dec 18, 2015
Objectives
To recognize how to conduct an adequate informed consent process in adults and children
To learn how to manage the process in special situations
To identify things to avoid when documenting the process
Topics Introduction Steps in the consent process Informed Consent Process (ICP) in Adults, special
considerations:o Does not speak Englisho Illiterate or Visually impairedo LAR in cases where subject cannot consent
ICP in Children, special considerations :o Child and parents do not speak Englisho Use of short form
Scenarios
Introduction
The are three elements involved in a successful participant enrollment. The elements include:o The informed consent form (ICF or ICD)o ICPo Consent documentation
Interdependent Elementso Poor documents undermine the process and vice versao Documenting the use of a poor form/process is GIGO
Steps in the consent process1. Provide enough information to
weigh risks/benefits of participation
2. Facilitate comprehension of the information
3. Give opportunities for Q&A4. Help with documentation5. Continue to provide
information: Ongoing process
ICP in Adults: Special Consideration
Participants who do not speak English Use of a translated ICF or short
form Oral translation of the English
language consent form is presented
There MUST be a translator There must be a witness to the
oral presentation
ICP in Adults: Special Consideration
Participants who do not speak English If using a short form, you may use
IRB approved short forms or submit an amendment for your own forms
If the IRB has not approved enrollment of non-English speaking subjects, an amendment will be required. o Include this in your original
submission!
ICP in Adults: Special Consideration
Participants who do not speak English (cont.) Subject (or LAR)
o Signs short form Investigator
o Signs ICF Translator
o Signs nothing (unless acting as witness) Witness
o Signs short form and ICF
ICP in Adults: Special Consideration
Illiterate or Visually impaired Person obtaining consent
o Reads entire form aloudo Documents subject unable to read
Opportunity for discussing questions and concerns is vital. o Repeating and explaining portions of the
Informed Consent Document.o Cover the document in stages.
ICP in Adults: Special Consideration
Illiterate or Visually impaired Requires a witness to verify
o Process took placeo Subject indicates understandingo Subject consented to participate.
“Making their mark” is sufficient.o Names and telephone contact numbers
for the study PI and the IRB Office should still be provided.
Legally authorized representative (LAR) considerations LAR = An individual authorized under law to consent on behalf
of a subject to participate in the procedure involved in the research
Research involving medical treatmento If an adult, make sure person is of sound mind and body, conscious,
mentally unimpaired and physically able to read and/or hear and understand; and has not been declared to be legally incompetent.
o If they are not, you need to use a LAR
ICP in Adults: Special Consideration
Legally authorized representative (LAR) considerations Research not involving medical
treatmento If an adult, you may not use a LAR if
the research does not involve medical treatment, unless there is a legal document (e.g. power of attorney that is specific for research).
ICP in Adults: Special Consideration
ICP in Children
Assent, not consent Verbal or Written Assent? If the parent of the child does not
speak English, do not use the child as the translator. You need a translator and the use a translated ICF or short form.
ICP in Children 1 or 2 parent signatures per IRB
approval letter If child is accompanied to the visit by
someone other than his/her parent, consider the following:o Medical research: Obtain legal
documentation. o Non-medical: you may not enroll subject
unless there is legal documentation specific to research consent.
ICP in ChildrenIf child is accompanied to the visit by someone other than a parent, consider the following: Medical research
o If minor is accompanied by grandparent or other relative that may be considered a LAR, ask why parent did not attend visit. • If parents are not available, but are the legal guardians (e.g. overseas for a
long period), make every effort to contact parent and make sure they agree with participation before adding child to study.
• If parents are not available/not able to serve as legal guardian (e.g., incapacitated), then family member may enroll child but should provide legal documentation to the study team.
o In general, if using a legal guardian, obtain legal documentation.
Scenarios You are doing a Phase II cancer trial study, and a non-English
speaking patients is eligible for it. The patient arrives alone to the clinic and speaks Mandarin. You do not have an ICF or short form approved. Which option is correct?
A. You may use the IRB short form in Mandarin. You did not have that approved before but the document is an IRB approved short form.
B. Have them sign the English version but get a translator from the hospital to sign as a witness.
C. Submit an amendment to select the option of enrolling non-English speaking subjects and use the IRB approved short form.
Scenarios You are doing a Phase II cancer trial study, and a non-English
speaking patients is eligible for it. The patient arrives alone to the clinic and speaks Mandarin. You do not have an ICF or short form approved. Which option is correct?
A. You may use the IRB short form in Mandarin. You did not have that approved before but the document is an IRB approved short form.
B. Have them sign the English version but get a translator from the hospital to sign as a witness.
C. Submit an amendment to select the option of enrolling non-English speaking subjects and use the IRB approved short form.
Scenarios You are approved to enroll non-English speaking subjects in
your pediatric, medical trial. You want to enroll a non-English speaking, 14 year-old child into the trial. What are the documents and procedures needed in this case (select the right option)
A. I need to translate the assent form, but not the ICF as I would be using a translator.
B. I need to use the short form (already approved by IRB) and use a translator for both the consent and assent.
C. I need to translate both documents (assent and ICF). I do not need to use a translator as the documents are already translated.
Scenarios You are approved to enroll non-English speaking subjects in
your pediatric, medical trial. You want to enroll a non-English speaking, 14 year-old child into the trial. What are the documents and procedures needed in this case (select the right option)
A. I need to translate the assent form, but not the ICF as I would be using a translator.
B. I need to use the short form (already approved by IRB) and use a translator for both the consent and assent.
C. I need to translate both documents (assent and ICF). I do not need to use a translator as the documents are already translated.
Scenarios You have talked to a parent about her child participating in a
non-medical trial. The day of the enrollment visit, the grandparent accompanies the child and say that the parent is not available.
A. You may not enroll the child unless the ICP is already approved by IRB (verbal consent).
B. You talked to the parent already, so the child can be enrolled by the grandparent.
C. You may not enroll unless the parent agrees to come the next day and sign the form again after child finishes with participation.
Scenarios You have talked to a parent about her child participating in a
non-medical trial. The day of the enrollment visit, the grandparent accompanies the child and say that the parent is not available.
A. You may not enroll the child unless the ICP is already approved by IRB (verbal consent).
B. You talked to the parent already, so the child can be enrolled by the grandparent.
C. You may not enroll unless the parent agrees to come the next day and sign the form again after child finishes with participation.
23
IRB Contacts:
Please call the QA and Education team Maria G. Davila
(404)712-0724 or [email protected] Shara Karlebach
(404)712-0727 or [email protected] Kevin Wack
(404)712-5220 or [email protected] Sean Kiskel
(404)712-0766 or [email protected]